GlassScriptPhysician profile
Joyce Kusuma
NPI 1144536145
$1,759.42
in general payments reported to CMS, 2019-2025
18 companies · $942 in 2025
The $942 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $275 · 2022: $215 · 2024: $327 · 2025: $942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,269.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $320.39 | 2021-2025 | Evenity |
| Lilly USA, LLC | $287.24 | 2021-2025 | Zepbound |
| Pfizer INC. | $189.86 | 2021-2022 | |
| Glaxosmithkline, LLC. | $147.71 | 2021-2025 | Benlysta |
| Dexcom, INC. | $132.08 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Boston Scientific Corporation | $122.99 | 2024 | Watchman Flx |
| Abbott Laboratories | $122.12 | 2025 | Freestyle Libre 3 |
| Radius Health, INC. | $115.00 | 2024 | Tymlos |
| Averitas Pharma INC. | $104.77 | 2025 | Qutenza |
| Janssen Pharmaceuticals, INC | $40.34 | 2021 | |
| Avion Pharmaceuticals | $33.90 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.11 | 2021 | |
| Xeris Pharmaceuticals, INC. | $23.25 | 2021 | |
| Alkermes, INC. | $21.65 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $20.33 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $17.29 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.92 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Kusuma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.